Search Results Search Sort by RelevanceMost Recent Policy Forum May 2003 The Virtue of Drawing Lines in Genetic Testing Rosemarie Tong, PhD Virtual Mentor. 2003;5(5):143-145. doi: 10.1001/virtualmentor.2003.5.5.pfor1-0305. State of the Art and Science Oct 2019 Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients? Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients. AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858.